BDBM62540 4-Chloro-3-(morpholine-4-sulfonyl)-N-pyridin-4-ylmethyl-benzamide::4-chloranyl-3-morpholin-4-ylsulfonyl-N-(pyridin-4-ylmethyl)benzamide::4-chloro-3-(4-morpholinylsulfonyl)-N-(pyridin-4-ylmethyl)benzamide::4-chloro-3-morpholin-4-ylsulfonyl-N-(pyridin-4-ylmethyl)benzamide::4-chloro-3-morpholinosulfonyl-N-(4-pyridylmethyl)benzamide::MLS000076032::SMR000014877::cid_647664

SMILES COCCn1nc2cc(N3CCOc4cc(C(=O)N5CCC(F)(F)CC5)cnc43)ccn2c1=O

InChI Key InChIKey=LYOKWBJVMORLCJ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62540   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62540BDBM62540(US12577217, Example 1-47)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent